DM

Devopum Mishra

Active Director Director DIN 08380590
DIN 08380590 First appointment Mar 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2019
Shareholding value •••• Premium profile

About Devopum Mishra

Data last updated:

Devopum Mishra is a Director at Protent Pharma Private Limited (since 2019). The company operates in Pharma. Protent Pharma Private Limited reported revenue of ₹42,119 (FY 2025).

DIN 08380590
Primary Designation Director
Industry Pharma
First Appointment 05 Mar 2019
Oldest Company Age 7 yrs
Largest company Protent Pharma Private Limited · ₹42,119 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Protent Pharma Private Limited U24100UP2019PTC114348
Director05 Mar 20192019₹42,119 (FY 2025)Active

Board colleagues of Devopum Mishra

Directorship timeline

Open interactive timeline →
Protent Pharma Private Limited
Premium access

Shareholding and investment profile for Devopum Mishra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Devopum Mishra

Devopum Mishra currently holds 1 directorship: Protent Pharma Private Limited (Director, since 05 Mar 2019, revenue ₹42,119 (FY 2025)).

Devopum Mishra was first appointed on 05 Mar 2019 as Director at Protent Pharma Private Limited.

The current boards of Devopum Mishra's companies include Dinesh Kumar (Protent Pharma Private Limited), Rahulkumar Santosh Tiwari (Protent Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available